The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sevoflurane, Isoflurane and Desflurane-Global Market Insights and Sales Trends 2024
Synopsis
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.
Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.
The global Sevoflurane, Isoflurane and Desflurane market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sevoflurane, Isoflurane and Desflurane in various end use industries. The expanding demands from the Cardiovascular Diseases, Respiratory Diseases, Cancer Diseases and Orthopedic Diseases, are propelling Sevoflurane, Isoflurane and Desflurane market. Sevoflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isoflurane segment is estimated at % CAGR for the next seven-year period.
Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sevoflurane, Isoflurane and Desflurane, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sevoflurane, Isoflurane and Desflurane market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sevoflurane, Isoflurane and Desflurane market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sevoflurane, Isoflurane and Desflurane sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sevoflurane, Isoflurane and Desflurane covered in this report include AbbVie, Baxter and Lunan Pharmaceutical Group, etc.
The global Sevoflurane, Isoflurane and Desflurane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Baxter
Lunan Pharmaceutical Group
Global Sevoflurane, Isoflurane and Desflurane market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sevoflurane, Isoflurane and Desflurane market, Segment by Type:
Sevoflurane
Isoflurane
Desflurane
Global Sevoflurane, Isoflurane and Desflurane market, by Application
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sevoflurane, Isoflurane and Desflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sevoflurane, Isoflurane and Desflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.
Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.
The global Sevoflurane, Isoflurane and Desflurane market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sevoflurane, Isoflurane and Desflurane in various end use industries. The expanding demands from the Cardiovascular Diseases, Respiratory Diseases, Cancer Diseases and Orthopedic Diseases, are propelling Sevoflurane, Isoflurane and Desflurane market. Sevoflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isoflurane segment is estimated at % CAGR for the next seven-year period.
Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sevoflurane, Isoflurane and Desflurane, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sevoflurane, Isoflurane and Desflurane market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sevoflurane, Isoflurane and Desflurane market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sevoflurane, Isoflurane and Desflurane sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sevoflurane, Isoflurane and Desflurane covered in this report include AbbVie, Baxter and Lunan Pharmaceutical Group, etc.
The global Sevoflurane, Isoflurane and Desflurane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Baxter
Lunan Pharmaceutical Group
Global Sevoflurane, Isoflurane and Desflurane market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sevoflurane, Isoflurane and Desflurane market, Segment by Type:
Sevoflurane
Isoflurane
Desflurane
Global Sevoflurane, Isoflurane and Desflurane market, by Application
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sevoflurane, Isoflurane and Desflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sevoflurane, Isoflurane and Desflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sevoflurane, Isoflurane and Desflurane Market Overview
1.1 Sevoflurane, Isoflurane and Desflurane Product Overview
1.2 Sevoflurane, Isoflurane and Desflurane Market Segment by Type
1.2.1 Sevoflurane
1.2.2 Isoflurane
1.2.3 Desflurane
1.3 Global Sevoflurane, Isoflurane and Desflurane Market Size by Type
1.3.1 Global Sevoflurane, Isoflurane and Desflurane Market Size Overview by Type (2018-2029)
1.3.2 Global Sevoflurane, Isoflurane and Desflurane Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Type (2018-2023)
2 Global Sevoflurane, Isoflurane and Desflurane Market Competition by Company
2.1 Global Top Players by Sevoflurane, Isoflurane and Desflurane Sales (2018-2023)
2.2 Global Top Players by Sevoflurane, Isoflurane and Desflurane Revenue (2018-2023)
2.3 Global Top Players by Sevoflurane, Isoflurane and Desflurane Price (2018-2023)
2.4 Global Top Manufacturers Sevoflurane, Isoflurane and Desflurane Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sevoflurane, Isoflurane and Desflurane Market Competitive Situation and Trends
2.5.1 Sevoflurane, Isoflurane and Desflurane Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sevoflurane, Isoflurane and Desflurane Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sevoflurane, Isoflurane and Desflurane as of 2022)
2.7 Date of Key Manufacturers Enter into Sevoflurane, Isoflurane and Desflurane Market
2.8 Key Manufacturers Sevoflurane, Isoflurane and Desflurane Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sevoflurane, Isoflurane and Desflurane Status and Outlook by Region
3.1 Global Sevoflurane, Isoflurane and Desflurane Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sevoflurane, Isoflurane and Desflurane Historic Market Size by Region
3.2.1 Global Sevoflurane, Isoflurane and Desflurane Sales in Volume by Region (2018-2023)
3.2.2 Global Sevoflurane, Isoflurane and Desflurane Sales in Value by Region (2018-2023)
3.2.3 Global Sevoflurane, Isoflurane and Desflurane Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Region
3.3.1 Global Sevoflurane, Isoflurane and Desflurane Sales in Volume by Region (2024-2029)
3.3.2 Global Sevoflurane, Isoflurane and Desflurane Sales in Value by Region (2024-2029)
3.3.3 Global Sevoflurane, Isoflurane and Desflurane Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sevoflurane, Isoflurane and Desflurane by Application
4.1 Sevoflurane, Isoflurane and Desflurane Market Segment by Application
4.1.1 Cardiovascular Diseases
4.1.2 Respiratory Diseases
4.1.3 Cancer Diseases
4.1.4 Orthopedic Diseases
4.1.5 Spinal Diseases
4.1.6 Gastro-Intestinal Diseases
4.2 Global Sevoflurane, Isoflurane and Desflurane Market Size by Application
4.2.1 Global Sevoflurane, Isoflurane and Desflurane Market Size Overview by Application (2018-2029)
4.2.2 Global Sevoflurane, Isoflurane and Desflurane Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales Breakdown by Application (2018-2023)
5 North America Sevoflurane, Isoflurane and Desflurane by Country
5.1 North America Sevoflurane, Isoflurane and Desflurane Historic Market Size by Country
5.1.1 North America Sevoflurane, Isoflurane and Desflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2018-2023)
5.1.3 North America Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2018-2023)
5.2 North America Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Country
5.2.1 North America Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2024-2029)
5.2.2 North America Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2024-2029)
6 Europe Sevoflurane, Isoflurane and Desflurane by Country
6.1 Europe Sevoflurane, Isoflurane and Desflurane Historic Market Size by Country
6.1.1 Europe Sevoflurane, Isoflurane and Desflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2018-2023)
6.1.3 Europe Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2018-2023)
6.2 Europe Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Country
6.2.1 Europe Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2024-2029)
6.2.2 Europe Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2024-2029)
7 Asia-Pacific Sevoflurane, Isoflurane and Desflurane by Region
7.1 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Historic Market Size by Region
7.1.1 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Region
7.2.1 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sevoflurane, Isoflurane and Desflurane Sales in Value by Region (2024-2029)
8 Latin America Sevoflurane, Isoflurane and Desflurane by Country
8.1 Latin America Sevoflurane, Isoflurane and Desflurane Historic Market Size by Country
8.1.1 Latin America Sevoflurane, Isoflurane and Desflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2018-2023)
8.2 Latin America Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Country
8.2.1 Latin America Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2024-2029)
9 Middle East and Africa Sevoflurane, Isoflurane and Desflurane by Country
9.1 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Historic Market Size by Country
9.1.1 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Forecasted Market Size by Country
9.2.1 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sevoflurane, Isoflurane and Desflurane Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Sevoflurane, Isoflurane and Desflurane Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Sevoflurane, Isoflurane and Desflurane Products Offered
10.1.5 AbbVie Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Introduction and Business Overview
10.2.3 Baxter Sevoflurane, Isoflurane and Desflurane Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Sevoflurane, Isoflurane and Desflurane Products Offered
10.2.5 Baxter Recent Development
10.3 Lunan Pharmaceutical Group
10.3.1 Lunan Pharmaceutical Group Company Information
10.3.2 Lunan Pharmaceutical Group Introduction and Business Overview
10.3.3 Lunan Pharmaceutical Group Sevoflurane, Isoflurane and Desflurane Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lunan Pharmaceutical Group Sevoflurane, Isoflurane and Desflurane Products Offered
10.3.5 Lunan Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sevoflurane, Isoflurane and Desflurane Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sevoflurane, Isoflurane and Desflurane Industrial Chain Analysis
11.4 Sevoflurane, Isoflurane and Desflurane Market Dynamics
11.4.1 Sevoflurane, Isoflurane and Desflurane Industry Trends
11.4.2 Sevoflurane, Isoflurane and Desflurane Market Drivers
11.4.3 Sevoflurane, Isoflurane and Desflurane Market Challenges
11.4.4 Sevoflurane, Isoflurane and Desflurane Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sevoflurane, Isoflurane and Desflurane Distributors
12.3 Sevoflurane, Isoflurane and Desflurane Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
